Rifaximin, an orally administered, semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity.An antibiotic that inhibits RNA synthesis and activates PXR.
Specifications and Purity: ≥97%
MDL Number: MFCD00864973
Molecular Formula: C43H51N3O11
Molecular Weight: 785.88
PubChem CID: 6436173
Isomeric SMILES: C[C@H]1/C=C/C=C(/C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)/C
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/R126176-SCI_f45796092b110f14d014a6c357c79b55.pdf
- UPC:
- 51141704
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- R126176-5g
- CAS:
- 80621-81-4
- Product Size:
- 5g
akash.verma@cenmed.com
(732) 447-1115





